Credit Suisse Starts Adeptus Biotechnologies Corp. (ADPT) at Underperform
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $25.44 --0%
Rating Summary:
13 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 17
Rating Summary:
13 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 17
Join SI Premium – FREE
Credit Suisse analyst Dan Leonard initiates coverage on Adeptus Biotechnologies Corp. (NASDAQ: ADPT) with a Underperform rating and a price target of $8.00.
For an analyst ratings summary and ratings history on Adeptus Biotechnologies Corp. click here. For more ratings news on Adeptus Biotechnologies Corp. click here.
Shares of Adeptus Biotechnologies Corp. closed at $10.75 yesterday.
You May Also Be Interested In
- BMO Capital Starts AMD (AMD) at Outperform
- BMO Capital Starts Marvell (MRVL) at Outperform
- BMO Capital Starts Semtech Corp. (SMTC) at Outperform
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
